Baylor College of Medicine clinical trial pipeline

15 trials changed in the last 30 days: 2 stopped, 7 with notable changes, 6 with minor changes only.

1. Stopped

   Disposable Endoscope Platform in Third Space Endoscopic Procedures

   Withdrawn before enrolling

   Sponsor's reason: The study was closed by the investigator prior to enrollment of any participants. The IRB has been notified and the study is closed.

   Also in this update: Primary completion pushed from Oct 31, 2026 to Sep 30, 2027; Completion pushed from Mar 31, 2027 to Dec 31, 2027

   Baylor College of Medicine·Not specified· NCT06738628· Registry history of NCT06738628 on ClinicalTrials.gov (opens the registry)

   Updated Oct 1, 2026

2. Stopped

   CALySSEY · CD70.CAR for CD70+ Lymphoma, Myeloma and Solid…CALySSEY · CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors

   Withdrawn before enrolling

   Sponsor's reason: The study was revised into two separate protocols to separate treatments. We will submit as separate studies.

   Baylor College of Medicine·Phase 1· NCT07297160· Registry history of NCT07297160 on ClinicalTrials.gov (opens the registry)

   Updated Sep 16, 2026

3. Notable

   Patch vs. No Patch Fetoscopic Meningomyelocele Repair Study

   Primary and study completion pushed from Aug 2026 to Dec 2027

   Baylor College of Medicine·Phase 1· NCT03794011· Registry history of NCT03794011 on ClinicalTrials.gov (opens the registry)

   Updated Oct 1, 2026

4. Notable

   Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in…Intra-Arterial Magnesium Therapy After Mechanical Thrombectomy in Acute Ischemic Stroke

   Primary completion pushed from Jun 2026 to Jul 2027

   Also in this update: Recruitment opened; Completion pushed from Jul 2026 to Jul 2027

   Baylor College of Medicine·Phase 1· NCT06956521· Registry history of NCT06956521 on ClinicalTrials.gov (opens the registry)

   Updated Oct 1, 2026

5. Notable

   DBS for Depression

   Primary and study completion pushed from Aug 19, 2026 to Aug 19, 2027

   Also in this update: Enrollment closed, study ongoing

   Baylor College of Medicine·Not applicable· NCT03437928· Registry history of NCT03437928 on ClinicalTrials.gov (opens the registry)

   Updated Oct 1, 2026

6. Notable

   Standardized Prenatal Clinical Care for LUTO

   Primary and study completion pushed from Nov 2026 to Dec 2027

   Baylor College of Medicine·Not specified· NCT02315521· Registry history of NCT02315521 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

7. Notable

   Neonatal Neurodevelopmental Outcomes

   Primary and study completion pushed from Aug 1, 2026 to Sep 1, 2027

   Baylor College of Medicine·Not specified· NCT07101757· Registry history of NCT07101757 on ClinicalTrials.gov (opens the registry)

   Updated Sep 30, 2026

8. Notable

   CASEY · Chimeric Antigen Receptor Treatment Targeting CD70…CASEY · Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

   Primary completion pushed from May 2027 to Jun 2029

   Also in this update: Recruitment opened; Enrollment increased: 12 → 78 participants

   Baylor College of Medicine·Phase 1· NCT06345027· Registry history of NCT06345027 on ClinicalTrials.gov (opens the registry)

   Updated Sep 16, 2026

9. Notable

   TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T…TRAIL-R2 and HER2 Bi-Specific Chimeric Antigen Receptor (CAR) T Cells · Metastatic Breast Cancer

   Recruitment opened

   Baylor College of Medicine·Phase 1· NCT06251544· Registry history of NCT06251544 on ClinicalTrials.gov (opens the registry)

   Updated Sep 24, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.